Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Survival on the rise among high-risk pulmonary embolism patients

The study's authors examined data from more than 1.4 million patients, noting that pulmonary embolism response teams appear to be playing a significant role. 

Medtronic has received FDA approval for its IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter

Medtronic gains FDA approval for new DCB compatible with 0.018” guidewires

The drug-coated balloon was approved to treat patients with peripheral arterial disease (PAD) in the superficial femoral and popliteal arteries

Dragonfly OpStar Imaging Catheter FDA recall May 2022

FDA announces Class I recall of 4,800 imaging catheters due to risk of vascular injury

There have been five reported incidents so far, including one patient injury.

Abdominal aortic aneurysm (AAA)

Open AAA repair linked to better long-term outcomes than EVAR

However, the authors noted, 30-day survival is significantly higher after EVAR than open AAA repair.  

Terry Bowers, MD, director of vascular medicine at Beaumont Hospital, Royal Oak, Michigan, and national co-chair of the Pulmonary Embolism Research Collaborative (PERC), explains the skillset needed for pulmonary embolism (PE) thrombectomy procedures. #PERT #PE

VIDEO: What interventional cardiologists need to perform pulmonary embolism thrombectomy

There is a national trend where cardiology is increasingly being called in to help with PE response teams (PERT) at hospitals. Terry Bowers from Beaumont explains what skills interventional cardiologists need for PE procedures.

Example of ultrasound-assisted laser arterial plaque removal, which might be developed into a new type of less traumatic atherectomy system.Image courtesy of Rohit Singh.

New atherosclerosis treatment uses ultrasound-assisted lasers to break down plaque

The new technique is still in the development stage, but early research suggests it could provide clinicians with a new treatment option for breaking down arterial plaque. 

Empagliflozin may reverse vascular aging, lower CVD risk

The SGLT2 inhibitor is already known as an effective medication for both type 2 diabetes and heart failure.

Anagrelide capsules FDA recall Teva Pharmaceuticals USA

FDA announces recall of platelet-reducing medication due to risk of clotting or other adverse cardiovascular outcomes

The medication failed a routine dissolution test, meaning it could lose its effectiveness.